A Medicine study used artificial intelligence to discover a naturally occurring molecule, specifically, a peptide, that ...

The study findings suggest a possible link between semaglutide use and an increased risk of NAION in patients with diabetes.

Pharma giant Novo Nordisk, which makes the obesity drug Wegovy, says the widespread availability of copycat medications is hurting its sales.

Dr Basavaraj GS from Narayana Health City, Bengaluru, explained that the real-world potential of another antidiabetic drug, ...

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...

Research shows weight loss surgery can help reduce the risk of severe liver problems for some patients with MASH.

ONE woman shared her experience on Ozempic after shedding a shocking amount of weight. She revealed that she dropped an ...

Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to LX9851, an ...

A groundbreaking study from the University of British Columbia has revealed a potentially disturbing side effect for those ...

Compounded versions could make up as much as 40% of the semaglutide market, said Novo Nordisk CEO Lars Fruergaard Jorgensen ...

Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.

A new study suggests that restoring the pleasure of eating – not suppressing it – may help people eat more intentionally and ...